In 2024, the global market for erectile dysfunction (ED) medications is worth around $2.9 billion. It’s expected to grow steadily, with a projected annual growth rate of 6.53% from 2024 through 2034. Among these treatments, Viagra continues to lead the way.
Viagra’s success is a prime example of how medical breakthroughs sometimes happen by accident. Originally developed to treat a different condition, the drug ended up transforming the way doctors treat erectile dysfunction.
In this article, we’ll explore how Viagra was discovered, what it was meant to treat, the key studies that shaped its development, and how it became a global success story.
What Was Viagra Originally Intended For?
In the mid-1980s, researchers at Pfizer’s lab in Sandwich, England, set out to develop a treatment for angina pectoris, a type of chest pain caused by reduced blood flow to the heart.
The goal was to create a drug that could dilate blood vessels, improve circulation, and relieve the chest pain that angina causes. Scientists believed that by relaxing the blood vessels, they could reduce the heart’s workload and increase oxygen supply.
By 1989, the Pfizer team had synthesized a compound called UK-92,480, which would later be known as sildenafil citrate.
This new molecule worked by inhibiting an enzyme called phosphodiesterase type 5 (PDE5). Inhibiting PDE5 helps keep blood vessels relaxed and open, which was expected to be beneficial for people suffering from angina.
Who Invented Viagra?

Scientists at Pfizer developed sildenafil, the active ingredient in Viagra. Key contributors included Dr. Nicholas Terrett and Dr. David Brown. Some sources also credit Peter Dunn and Albert Wood, though their roles are less clearly documented.
How Was Viagra Discovered?
In an interview with The Guardian, Dr. David Brown recalled that by 1993, the outlook for sildenafil wasn’t good. Pfizer had grown frustrated after years of investment without meaningful results. The company was ready to shut down the program entirely, seeing it as a failed effort.
As a final attempt, Brown and his team ran one last trial at a clinic in Merthyr Tydfil, a former coal-mining town in south Wales that had been hit hard by unemployment.
Volunteers were offered £300 to take part in the study, which involved staying overnight at the clinic for observation and blood sampling. The researchers hoped that increasing the dosage might finally produce better results for angina.
The following morning, participants were asked to complete a questionnaire that included a section on any unusual effects they had experienced. According to Brown, one man hesitantly mentioned experiencing spontaneous erections throughout the night. Other participants then reported similar effects.
Brown quickly realized the significance of what they had stumbled upon. The compound, intended to relax blood vessels around the heart, was also enhancing blood flow to the penis.
This side effect, while unrelated to angina, hinted at a completely different and potentially lucrative use–treating erectile dysfunction (ED).
In the early 1990s, ED was a condition with limited treatment options, often involving painful injections or awkward mechanical devices. A simple, oral medication that worked by enhancing natural physiological processes offered a groundbreaking alternative.
When Was Viagra Released?

Recognizing the potential, Pfizer redirected its focus, conducting trials specifically targeting ED. The results were promising, leading to the US Food and Drug Administration (FDA) approving sildenafil for the treatment of erectile dysfunction on March 27, 1998.
It became the first oral treatment for ED, marketed under the brand name Viagra, offering a convenient and effective solution.
Viagra’s introduction was met with significant demand. Within its first year, it generated over $1 billion in sales, marking one of the most successful pharmaceutical launches in history.
The drug’s success reshaped public discourse around male sexual health and inspired the development of other PDE5 inhibitors like Cialis (tadalafil) and Levitra (vardenafil).
Beyond ED, sildenafil has been found useful in treating pulmonary arterial hypertension (PAH), a condition characterized by high blood pressure in the lungs’ arteries. In 2005, the FDA approved sildenafil under the brand name Revatio for this indication, showcasing the drug’s versatility.
Wrap-up
Viagra was originally developed to treat angina by improving blood flow to the heart. Although it didn’t work well for that purpose, researchers discovered it unexpectedly caused erections.
This led Pfizer to shift focus and test it for erectile dysfunction instead. After successful trials, the FDA approved Viagra in 1998, making it the first oral ED medication. It quickly became a blockbuster drug and changed how sexual health was treated.
Frequently Asked Questions
Related Articles
Sources
Erectile Dysfunction Drugs Market Size, Share & Trends Analysis Report by product (Viagra, Cialis, Levitra/Staxyn), by mode of administration (Oral, Injectable), by region, and segment Forecasts, 2025 – 2030. (n.d.). https://www.grandviewresearch.com/industry-analysis/erectile-dysfunction-drugs-market
BioSpace. (2024, July 15). Erectile Dysfunction market to reach USD 3.9 billion by 2034, driven by product innovations and expanding treatment awareness. https://www.biospace.com/erectile-dysfunction-market-to-reach-usd-3-9-billion-by-2034-driven-by-product-innovations-and-expanding-treatment-awareness
Wilson, J. (2013, March 27). Viagra: The little blue pill that could. CNN. https://edition.cnn.com/2013/03/27/health/viagra-anniversary-timeline/index.html
Devlin, H. (2023, December 2). ‘It wouldn’t exist’: Viagra inventor tells how Welsh miners began its rise. The Guardian. https://www.theguardian.com/lifeandstyle/2023/dec/02/viagra-inventor-welsh-miners-began-rise-dr-david-brown
Kenny, U. (2002, March 31). Drug innovators: Dr Nick Terret and Dr Ian Osterloh, Viagra. The Guardian. https://www.theguardian.com/theobserver/2002/mar/31/features.magazine37
Shead, S. (2018, July 26). Viagra inventor raises $10m to find medicines for rare diseases with AI. Forbes. https://www.forbes.com/sites/samshead/2018/07/26/viagra-inventor-raises-10m-to-find-medicines-for-rare-diseases-with-ai/
Smith, B. P., & Babos, M. (2023, February 14). Sildenafil. StatPearls – NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK558978/
Nocera, J. (2017, December 6). Viagra History from sex icon to generic drug. Bloomberg.com. https://www.bloomberg.com/view/articles/2017-12-06/viagra-history-from-sex-icon-to-generic-drug?embedded-checkout=true
Lovelace, B., Jr. (2019, May 15). How Viagra revolutionized the erectile dysfunction market. CNBC. https://www.cnbc.com/2019/05/10/how-viagra-revolutionized-the-erectile-dysfunction-market.html
Osterloh, I. H. (2004). The discovery and development of Viagra® (sildenafil citrate). In Birkhäuser Basel eBooks (pp. 1–13). https://doi.org/10.1007/978-3-0348-7945-3_1




